Tesamorelin 10mg

Tesamorelin is a modified form of human GHRH (1-44) with the trans-3-hexenoyl group at the N-terminus to improve pharmacokinetic properties in experimental models. In controlled preclinical and in-vitro research, it is utilized to study GHRH receptor activation, somatotropic axis modulation, growth hormone (GH) secretion dynamics, IGF-1 pathway interactions, and related endocrine signaling in non-human systems such as pituitary cell cultures or receptor binding assays. The modification contributes to prolonged activity, allowing researchers to investigate sustained GH release patterns without frequent re-dosing in lab setups.

This peptide serves as a valuable tool for exploring hypothalamic-pituitary signaling, peptide stability, receptor-ligand kinetics, and metabolic pathway responses in biochemical and cellular research contexts.

Critical Compliance and Safety Notice: Peptide Source supplies tesamorelin strictly for research laboratory use only (in-vitro experiments, cell-based assays, receptor pharmacology, endocrine studies, etc.). This product is not intended, approved, or safe for human use, consumption, self-administration, therapeutic purposes, fat reduction, HIV-related applications, diagnosis, or any non-research application. It is not for food, drug, cosmetic, or veterinary use. Researchers are responsible for proper handling, storage, and adherence to institutional biosafety protocols and regulations. Peptide Source provides no medical advice and prohibits any misuse. Certificates of Analysis (COA) are available upon request to confirm purity, identity, and quality.

Peptide Source is a trusted supplier of premium research peptides like tesamorelin 10mg, with rigorous quality control, secure packaging, and fast worldwide shipping (including Greece). Contact us for bulk options or additional documentation.